Form 4: Jazz Pharmaceuticals EVP Neena M Patil Reports Stock Transaction
SEC Form 4 Filing
Neena M Patil, EVP & Chief Legal Officer of Jazz Pharmaceuticals, reports the disposal of 3,432 ordinary shares to cover tax obligations.
Summary
- On March 5, 2024, Neena M Patil, EVP & Chief Legal Officer of Jazz Pharmaceuticals plc, disposed of 3,432 ordinary shares.
- The shares were withheld to satisfy tax obligations arising from the vesting of restricted stock units.
- The transaction price was $117.53 per share.
- Following the transaction, Patil directly owns 41,629 ordinary shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction related to tax obligations.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it's a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/05/2024 | Date of stock transaction (disposal of shares) |
| 03/07/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.